Skip to main content

Walsh Patrick D's Form 4 filing

Ani Pharmaceuticals IncANIP · filed Nov 17, 2025

Accession no.
0001720568-25-000007
Filed
Nov 17, 2025
Trade date
Nov 13, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market sales total $750.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walsh Patrick DCIK 0001720568Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2025Common StockSSaleDisposed−8,643$86.88F1−$750,903.8461,405Direct
Nov 13, 2025Common StockGGiftDisposed−3,000$0.00$058,405Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The shares were sold in multiple trades at prices ranging from $86.15 to $87.80. The price reported above reflects the weighted average sales price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)